norml scholarships drug policy reform conference
Marijuana Science Medical Marijuana Policy

NORML’s Emerging Clinical Applications For Cannabis And Cannabinoids

norml scholarships drug policy reform conferenceBy Paul Armentano, NORML Deputy Director

NORML is pleased to present the latest expanded/updated edition of the publication Emerging Clinical Applications for Cannabis & Cannabinoids — a comprehensive review of the latest peer-reviewed science specific to the safety and therapeutic efficacy of whole-plant cannabis and/or its components.

The 2015 updated edition includes two additional disease profiles (Parkinson’s disease and PTS) and includes summaries of an additional 50+ relevant clinical and/or preclinical trials specific to cannabinoids’ therapeutic utility. Several existing sections, such as Chronic Pain, Diabetes, and Epilepsy, have been significantly expanded since the last edition (January 2013). Also updated is the Introduction to the Endocannabinoid System (authored by Dustin Sulak, DO) and Why I Recommend Medical Cannabis (authored by Estelle Goldstein, MD).

With summaries and citations of well over 250 recent peer-reviewed studies, this updated publication is one of the most thorough and up-to-date source-books available specific to documenting the established therapeutic qualities of cannabis. The updated publication is available online here.

Individual sections of this publication may be accessed at the links below:

Author’s Introduction
Foreword
Introduction to the Endocannabinoid System
Why I Recommend Medical Cannabis
Alzheimer’s Disease
Amyotrophic Lateral Sclerosis
Chronic Pain
Diabetes Mellitus
Dystonia
Epilepsy
Fibromyalgia
Gastrointestinal Disorders
Gliomas/Cancer
Hepatitis C
Human Immunodeficiency Virus
Huntington’s Disease
Hypertension
Incontinence
Methicillin-resistant Staphyloccus aureus (MRSA)
Multiple Sclerosis
Osteoporosis
Parkinson’s Disease
Post-Traumatic Stress
Pruritus
Rheumatoid Arthritis
Sleep Apnea
Tourette’s Syndrome

Source: NORML - make a donation

  • Trichometrist

    #efficacy

  • PhDScientist

    Kudos to NORML. Marijuana isn’t just a “Wonder Drug” its “a rain forest in a single plant”
    We need the President to take Marijuana off of Schedule 1 before foreign drug companies patent every biochemical in it.
    Google GWPH.

  • PhDScientist

    We need NORML’s help in getting Marijuana taken off of Schedule 1 immediately. We’re trying to get as many people as possible to call the White House comment line every day until the President takes personal action on this issue, either by executive order to remove Marijuana from Schedule 1 or by directing Attorney General Lynch to do it.
    Can NORML help in this effort?

  • Robert Platshorn

    The first ever national cannabis education campaign begins tomorrow. Next week alone, The Silver Tour will air 1,439 “Cannabis Facts” on top radio stations in 6 key states. If you’ve ever said, “If people only knew”, rejoice! Here is next week’s coverage.
    Florida 637 spots on 15 stations from Miami to the Panhandle. Georgia-324 spots in Atlanta, Columbus and Savannah. Texas-240 spots in 8 markets including Houston, Waco, El Paso and more. Pennsylvania-101 spots in Central Pa. Ohio-65 spots in Columbus, Dayton and Toledo. Tennessee-49 spots in Nashville and Memphis.
    States, messages and stations will vary week to week. Donors and sponsors can request specific coverage areas. By the 2016 elections, we will cover the entire country and with your support we will end cannabis prohibition. Listen to this week’s “Cannabis Facts”. https://soundcloud.com/robert-pl…/…/silver-tour-nation-radio

    . Please help inform America-Donate or become a sponsor. http://ow.ly/RQPp3